CS252636B1 - O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines - Google Patents

O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines Download PDF

Info

Publication number
CS252636B1
CS252636B1 CS863354A CS335486A CS252636B1 CS 252636 B1 CS252636 B1 CS 252636B1 CS 863354 A CS863354 A CS 863354A CS 335486 A CS335486 A CS 335486A CS 252636 B1 CS252636 B1 CS 252636B1
Authority
CS
Czechoslovakia
Prior art keywords
pyrazolo
dihydro
oxo
dimethyl
hydroxy
Prior art date
Application number
CS863354A
Other languages
Czech (cs)
Other versions
CS335486A1 (en
Inventor
Viktor Zikan
Stanislav Radl
Original Assignee
Viktor Zikan
Stanislav Radl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viktor Zikan, Stanislav Radl filed Critical Viktor Zikan
Priority to CS863354A priority Critical patent/CS252636B1/en
Publication of CS335486A1 publication Critical patent/CS335486A1/en
Publication of CS252636B1 publication Critical patent/CS252636B1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Řešení se týká O-substituovaných 4,9-dihydro-6-hydroxy-3,9-dimethyl-4- -σχο-ΙΗ-pyrazolo(3,4-b)chinolinů obecného vzorce I kde R je atom vodíku nebo methylskupina. Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.The present invention relates to O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4- -σχο-β-pyrazolo (3,4-b) quinolines of Formula I wherein R is hydrogen or methyl. These new, not yet described, substances are useful as intermediates for the preparation of substances showing significant \ t biological effects, especially antiviral and anti-tumor effect.

Description

Vynález se týká 0-substituovaných 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolinů obecného vzorce IThe present invention relates to O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinolines of formula I

kde R je atom vodíku nebo methylskupina.wherein R is hydrogen or methyl.

Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zvláště protivirový a protinádorový účinek.These novel substances, which have not been described yet, are useful as intermediates for the preparation of substances having significant biological effects, in particular antiviral and antitumor activity.

Sloučeninu obecného vzorce I, kde R je methylskupina, lze podle vynálezu připravit z kondenzačního produktu 4-(4-methoxyfenyl)-4-methyl-thiosemikarbazidu s 2-chloracetoctanem ethylnatým, a to cyklizací polyfosforečnou kyselinou za zvýšené teploty.The compound of formula (I) wherein R is methyl can be prepared from the condensation product of 4- (4-methoxyphenyl) -4-methylthiosemicarbazide with ethyl 2-chloroacetate by cyclization with polyphosphoric acid at elevated temperature.

Sloučeninu obecného vzorce I, kde R je atom vodíku, lze podle vynálezu připravit z 4,9-dihydro-6-methoxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolinu demethylací varem s azeotropickou bromovodíkovou kyselinou.A compound of formula I wherein R is hydrogen may be prepared according to the invention from 4,9-dihydro-6-methoxy-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline by boiling demethylation azeotropic hydrobromic acid.

Sloučeninu obecného vzorce I, kde R je atom vodíku, lze také připravit podle vynálezu z 4,9-dihydro-6-methoxy-l,3,9-trimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolinu nebo z 4,9-dihydro-2,3,9-trimethyl-4-oxo-6-methoxy-2H-pyrazolo(3,4-b)chinolinu demethylací hydrochloridem pyridinu za zvýšené teploty.A compound of formula I wherein R is hydrogen may also be prepared according to the invention from 4,9-dihydro-6-methoxy-1,3,9-trimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline or from 4,9-dihydro-2,3,9-trimethyl-4-oxo-6-methoxy-2H-pyrazolo (3,4-b) quinoline by demethylation of pyridine hydrochloride at elevated temperature.

Způsob přípravy látek je jednoduchý, produkty jsou získávány v uspokojivých výtěžcích v kvalitě přímo použitelné k dalšímu zpracování.The method of preparation of the substances is simple, the products are obtained in satisfactory yields in a quality directly applicable for further processing.

Bližší podrobnosti vyplývají z následujících příkladů provedení. Uvedené příklady vynález pouze ilustrují, nikoliv omezují.Further details are given in the following examples. The examples given are merely illustrative and not limiting.

Příklad 1Example 1

4.9- Dihydro-6-methoxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolin4.9-Dihydro-6-methoxy-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline

K míchané suspenzi 4-(4-methoxyfenyl)-4-methyl-thiosemikarbazidu (10,5 g, 50 mmol) v ethanolu (250 ml) byl za míchání přidán 2-chloracetoctan ethylnatý (8,5 g, 52 mmol) a směs byla míchána 2 hodiny za teploty místnosti a poté 0,5 hodiny povařena.To a stirred suspension of 4- (4-methoxyphenyl) -4-methyl-thiosemicarbazide (10.5 g, 50 mmol) in ethanol (250 mL) was added ethyl 2-chloroacetacetate (8.5 g, 52 mmol) with stirring. was stirred for 2 hours at room temperature and then boiled for 0.5 hours.

Po odfiltrování vyloučené síry byl roztok odpařen k suchu a odparek byl smíchán s polyfosforečnou kyselinou (100 g, 85 % P2°5* a sm®s byla míchána 2 hodiny při teplotě 90 °C. Reakční směs byla vlita do vody (1 000 ml), ochlazena, nerozpustný podíl byl odsát, překrystalován z ethanolu. Bylo získáno 7,0 g látky (58 %) o t.t. 317 až 323 °C.After filtration of the precipitated sulfur, the solution was evaporated to dryness and the residue was mixed with polyphosphoric acid (100 g, 85% P 2 ° 5 * and SM ® Sb y la stirred for 2 hours at 90 ° C. The reaction mixture was poured into water (1 000 ml), cooled, insoluble material was aspirated, recrystallized from ethanol to give 7.0 g (58%) of mp 317-332 ° C.

Příklad 2Example 2

4.9- Dihydro-6-hydroxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolin4.9-Dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline

Směs 4,9-dlhydro-6-methoxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolinu (16,1 g, mmol) a azeotropické bromovodíkové kyseliny (265 ml) byla vařena pod zpětným chladičem hodin. Po ochlazení byl nerozpustný podíl odsát a překrystalován z monomethyletheru ethylenglykolu. Bylo získáno 14,1 g látky (93 %) o t.t. 343 až 348 °C.A mixture of 4,9-dlhydro-6-methoxy-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline (16.1 g, mmol) and azeotropic hydrobromic acid (265 mL) was boiled under reflux for hours. After cooling, the insoluble material was aspirated and recrystallized from ethylene glycol monomethyl ether. 14.1 g (93%) of m.p. Mp 343 - 348 ° C.

Příklad 3Example 3

4.9- Dihydro-6-hydroxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolin4.9-Dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline

Míchaná směs pyridinu (20 g) a koncentrované chlorovodíkové kyseliny (30 ml) byla postupně zahřívána na 160 °C. Při této teplotě byl přidán 4,9-dihydro-6-methoxy-l,3,9-trimethyl-4-oxo-lH-pyrazolo(3,4-b)chinolin (5,1 g, 20 mmol) a směs byla 10 hodin míchána při teplotě 220 °C.A stirred mixture of pyridine (20 g) and concentrated hydrochloric acid (30 mL) was gradually heated to 160 ° C. 4,9-Dihydro-6-methoxy-1,3,9-trimethyl-4-oxo-1H-pyrazolo (3,4-b) quinoline (5.1 g, 20 mmol) was added at this temperature and the mixture was Stirred at 220 ° C for 10 hours.

Směs byla vlita do vody (150 ml), povařena s aktivním uhlím a zfiltrována. Filtrát byl ochlazen a vyloučené krystaly byly odsáty, promyty vodou a překrystalovány z ethanolu. Bylo získáno 1,1 g látky (22 %) o t.t. 343 až 348 °C.The mixture was poured into water (150 mL), boiled with activated carbon and filtered. The filtrate was cooled and the precipitated crystals were filtered off with suction, washed with water and recrystallized from ethanol. 1.1 g (22%) of m.p. Mp 343 - 348 ° C.

Příklad 4Example 4

4.9- Dihydro-6-hydroxy-3,9-dimethyl-4-oxo-lH-pyrazolo (3,4^-b) chinolin4.9-Dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline

Směs bezvodého hydrochloridu pyridinu (40 g) a 4,9-dihydro-6-methoxy-2,3,9-trimethyl-4-oxo-2H-pyrazolo(3,4-b)chinolinu (2,0 g, 7,8 mmol) byla míchána pod dusíkem 4 hodiny při teplotě 220 °C. Zpracováním popsaným v příkladu 3 bylo získáno 0,65 g látky (34 %) o t.t. 343 až 348 °C.A mixture of anhydrous pyridine hydrochloride (40 g) and 4,9-dihydro-6-methoxy-2,3,9-trimethyl-4-oxo-2H-pyrazolo (3,4-b) quinoline (2.0 g, 7, 8 mmol) was stirred under nitrogen at 220 ° C for 4 hours. The work-up described in Example 3 afforded 0.65 g (34%) of m.p. Mp 343 - 348 ° C.

Claims (1)

O-Substituované 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-lH-pyrazolo(3,4-b)chinoliny obecného vzorce IO-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1H-pyrazolo (3,4-b) quinolines of formula I -CH·,-CH ·, CH3 H (I), kde R je atom vodíku nebo methylskupina.CH 3 H (I), wherein R is hydrogen or methyl.
CS863354A 1986-05-08 1986-05-08 O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines CS252636B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS863354A CS252636B1 (en) 1986-05-08 1986-05-08 O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS863354A CS252636B1 (en) 1986-05-08 1986-05-08 O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines

Publications (2)

Publication Number Publication Date
CS335486A1 CS335486A1 (en) 1987-02-12
CS252636B1 true CS252636B1 (en) 1987-09-17

Family

ID=5373333

Family Applications (1)

Application Number Title Priority Date Filing Date
CS863354A CS252636B1 (en) 1986-05-08 1986-05-08 O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines

Country Status (1)

Country Link
CS (1) CS252636B1 (en)

Also Published As

Publication number Publication date
CS335486A1 (en) 1987-02-12

Similar Documents

Publication Publication Date Title
US3850941A (en) 2-alkyl-3-acylpyrazolo(1,5-a)pyridines
KR880002232B1 (en) Preparation process for quinoline derivatives and their salts
CZ20003871A3 (en) Dihydropyrimidines, process of their preparation, medicaments containing such substances and their use
JPH0327381A (en) Olefin 1h-imidazo (4,5-c1) quinoline-4-amine
JPS63275582A (en) Production of 1-aminoimidazo(4,5-b)pyridine derivative
CZ20013658A3 (en) Synthesis and crystallization of compounds containing piperazine ring
SU722481A3 (en) Method of preparing aminoketone derivatives or their salts
US3960856A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
CS252636B1 (en) O-substituted 4,9-dihydro-6-hydroxy-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b)quinolines
DE1176660B (en) Process for the preparation of triaryl-substituted imidazolinones-4 (5)
CZ299329B6 (en) Process for preparing 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy camptothecin
US6545149B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
JPH0121828B2 (en)
US4182880A (en) 1,8-Naphthyridine compounds and process for preparing the same
KR880000154B1 (en) The method of preparation for amino-nitro pyridine
US20040176591A1 (en) Novel synthesis and crystallization of peperazine ring-containing compounds
CS252341B1 (en) O,n-substituted 4,9-dihydro-6-hydroxy-1,3-dimethyl-4-oxo-1hpyrazolo(3,4-b)quinolines
EP0393109A1 (en) Novel 2,3-thiomorpholinedione-2-oxime derivatives, pharmaceutical compositions containing them and process for preparing same.
CS252340B1 (en) 4-chloro-6-methoxy-3-methyl-1h-pyrazolo(3,4-b)quinoline and its n1-methylderivative
CS252342B1 (en) O,n-substituted 4,9-didydro-6-hydroxy-2,3-dimethyl-4-oxo-2h-pyrazolo(3,4-)quinolones
JPS6299363A (en) Phenylbarbituric acids
JPH0670061B2 (en) 2-Piperidinoamino-substituted pyrimidopyrimidine derivatives
DE3705935A1 (en) One-pot process for the preparation of 3-amino-1-(4,5,6,7-tetrahydro-2-benzothiazolyl)-2-pyrazolines
PL152486B1 (en) Method of obtaining novel n-aminomethyl 1,2-benzoisothiazolynon-3-yl-acetamide
JPH0441146B2 (en)